Latest Funding Agreements News

Celsius Resources has obtained a six-month extension to meet funding conditions for its flagship MCB Project, while progressing engineering design and maintaining a stable cash position of A$1.053 million.

Minbos Resources has officially commenced construction on its Cabinda Phosphate Fertilizer Project, supported by a robust US$36 million financing package from strategic partners including Angola’s Sovereign Wealth Fund and Banco BAI.

Arcadia Minerals reports ongoing joint venture discussions across its Namibian projects and initiates a competitive bidding process for Swanson Tantalum Mine construction financing following a funding agreement termination.

Opthea Limited reports steady progress in its Phase 3 trials for sozinibercept, a novel treatment for wet AMD, supported by a strong cash position and a recent R&D tax incentive.

Peak Rare Earths Limited has made significant strides in developing its Ngualla Rare Earth Project, completing an $8.5 million capital raise and progressing key negotiations with Shenghe Resources. Community initiatives and asset sales further underpin its growth strategy.

Imugene Limited reports durable patient responses in multiple cancer immunotherapy trials and strengthens its financial position with a $46 million convertible note deal and a substantial R&D tax refund.

Finder Energy reports significant progress in its Kuda Tasi and Jahal oil fields development, including promising production simulations and active partner engagement for funding. The company also advances exploration efforts in the UK North Sea and Australia, maintaining a solid cash position.

Silver Mines Limited has secured $25 million in funding and released an updated Ore Reserve and Optimisation Study for its flagship Bowdens Silver Project, reinforcing its position as a leading silver developer in Australia.

Ioneer Ltd has closed a $996 million loan from the U.S. Department of Energy to accelerate its Rhyolite Ridge Lithium-Boron Project in Nevada, following key federal permitting milestones. Construction is targeted for 2025, promising to boost domestic critical mineral supply and create hundreds of jobs.

InhaleRx has corrected its quarterly report and revealed a $38.5 million funding deal to fast-track clinical trials for its inhaled therapies targeting breakthrough cancer pain and panic disorder, aiming for FDA approval.

Volt Resources Limited has successfully repaid a AU$500,000 loan to RiverFort Global Opportunities, underscoring its financial discipline amid ongoing graphite project developments.

International Graphite advances its vision of a fully integrated graphite supply chain in Western Australia, securing significant government funding and delivering promising drilling and testwork results at its Springdale project.